Tag Archives: plan sponsor

Did You Know Market Access is Closing Down

Biopharma companies need to see the employer market clearly in the short and long-term to be able to understand payers management methods for orphan drugs and the impact those decisions will have on their drugs

Optum Specialty Fusion™ Launched To Streamline Care and Lower Costs

Optum Specialty Fusion™ was launched to streamline treatment decision-making for care providers, helping patients get on their therapies faster

Aetna Launches New Network to Cover New Gene Therapies for Rare Diseases

Aetna recently announced an initiative to launch a designated network to cover new gene therapies for rare diseases. This follows an initiative by CVS Health in 2019 to provide self-insured employers with a stop-loss program with Aetna health plans and cover gene therapies

Centene’s Restructuring Initiative Focuses on Behavioral Health and Pharmacy Growth

Centene’s recent acquisition of PANTHERx will play a major role in the company’s specialty pharmacy growth

AscellaHealth and BioMatrix Specialty Pharmacy Strengthen Relationship

BioMatrix offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions

Market Access Programs for Gene Therapies Increasing

Payers are planning for an increasing number of gene therapies being approved by developing new coverage programs

Oncology Biosimilars: Opportunity or Not?

Oncology Biosimilars: Opportunity or Not? VBCC – April 2016, Vol 7, No 3 – Employers’ Perspective F. Randy Vogenberg, PhD, RPh, Partner Access Market Intelligence Martha M. Rumore, PharmD, JD, MS, LLM, FAPhA The United States has the largest biologic drugs market and high prices for biologics, such as monoclonal antibodies, therapeutic proteins, immunomodulators, and […]

Big Data in Cancer Care: Limitations of Drug Claims

Big Data in Cancer Care: Limitations of Drug Claims VBCC – March 2016, Vol 7, No 2 – Employers’ Perspective Catherine E. Cooke, PharmD, BCPS F. Randy Vogenberg, PhD, RPh Partner, National Institute of Collaborative Healthcare, and Access Market Intelligence; Principal, Institute for Integrated Healthcare Greenville, SC As one part of an ongoing macrotheme regarding big […]